SEC Form 4 · accession 0001127602-16-060458
Elevance Health, Inc. · ELV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Swedish
Officer — Chair, President & CEO · Director
Period of report
Aug 12, 2016
Accepted (ET)
Aug 17, 2016 · 12:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001156039
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 12, 2016 | S | 8,071 | $130.36 | D | 103,823 | D | |
| Common Stock | Aug 12, 2016 | S | 100 | $131.05 | D | 103,723 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2016.
- F2This transaction was executed in multiple trades at prices ranging from $130.00 to $130.94. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.